Paul Edward Walker's Net Worth
Estimate Recalculated Apr 25, 2026 02:11PM EST
Who is Paul Edward Walker
Paul Edward Walker does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include TESARO, Inc., Allakos Inc., NeueHealth, Inc., Monte Rosa Therapeutics, Inc., Mirum Pharmaceuticals, Inc., Metacrine, Inc., Trillium Therapeutics Inc., Savara Inc, Trevi Therapeutics, Inc., Tracon Pharmaceuticals, Inc., Akouos, Inc., Black Diamond Therapeutics, Inc., Marker Therapeutics, Inc., GENOCEA BIOSCIENCES, INC., Regulus Therapeutics Inc., and Korro Bio, Inc..
SEC CIK
Paul Edward Walker's CIK is 0001553150
Past Insider Trading and Trends
2013 was Paul Edward Walker's most active year for acquiring shares with 2 total transactions. Paul Edward Walker's most active month to acquire stocks was the month of May. 2021 was Paul Edward Walker's most active year for disposing of shares, totalling 1 transactions. Paul Edward Walker's most active month to dispose stocks was the month of October. 2022 saw Paul Edward Walker paying a total of $0.00 for 99,590 shares, this is the most they've acquired in one year. In 2021 Paul Edward Walker cashed out on 40,000 shares for a total of $0.00, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
